INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments
Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties
-
Best Practices For Operationalizing Global, Early-Phase Oncology Trials
In this presentation, industry experts will share real-world lessons learned from managing global early-phase oncology trials.
-
Scalable Payments For Global Clinical Studies
How does a global clinical trial scale change payment behavior, and how can teams spot when payment operations start slowing execution?
-
Unanticipated Roadblocks In Ovarian Cancer Drug Development
Enhance your Ovarian cancer trials by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.
-
How Sponsors, CROs, And Tech Vendors Can Reduce Site Tech Overload10/10/2024
Sites juggle dozens of applications, which increases their workload and limits their capacity. Sites need an industry-wide single sign-on experience that brings key systems and applications under one roof.
-
Accelerate Drug Development With Master Protocols5/15/2025
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
The Lasting Impact Of Treatment Gaps In ARG1-D6/26/2026
A patient story from ARG1-D reveals how even brief treatment interruptions can trigger irreversible decline and why continuity of care must remain a priority in rare disease research.
-
Insights From Facilitating Over A Billion Dollars In Vendor Contracts7/1/2025
By transforming vendor selection from a manual task into a data-driven, strategic process, sponsors can build stronger, more effective clinical trial teams.
-
Podcast — Strategic Site Identification: A Proven Approach11/20/2024
Watch our new podcast to discover Altasciences' unique process for identifying and selecting the right clinical sites for your unique project.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
One Home for Sites is a vendor-agnostic, sponsor-agnostic, aggregation platform that provides single sign-on and more. Become part of the only industry-wide solution to site tech overload.
-
Built for Sites, Not Just Sponsors
Too many recruitment vendors focus solely on the sponsor’s bottom line, leaving sites stuck managing clunky spreadsheets, manual tracking, and outreach tasks without the infrastructure to scale.
-
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
Citeline’s Consulting & Analytics team helps clinical trials harness the power of real-world data (RWD) by transforming raw numbers into actionable insights.